256 related articles for article (PubMed ID: 34591857)
1. The Candida glabrata Upc2A transcription factor is a global regulator of antifungal drug resistance pathways.
Vu BG; Stamnes MA; Li Y; Rogers PD; Moye-Rowley WS
PLoS Genet; 2021 Sep; 17(9):e1009582. PubMed ID: 34591857
[TBL] [Abstract][Full Text] [Related]
2. Evidence that Ergosterol Biosynthesis Modulates Activity of the Pdr1 Transcription Factor in Candida glabrata.
Vu BG; Thomas GH; Moye-Rowley WS
mBio; 2019 Jun; 10(3):. PubMed ID: 31186322
[TBL] [Abstract][Full Text] [Related]
3. UPC2A is required for high-level azole antifungal resistance in Candida glabrata.
Whaley SG; Caudle KE; Vermitsky JP; Chadwick SG; Toner G; Barker KS; Gygax SE; Rogers PD
Antimicrob Agents Chemother; 2014 Aug; 58(8):4543-54. PubMed ID: 24867980
[TBL] [Abstract][Full Text] [Related]
4. Nonidentical function of Upc2A binding sites in the Candida glabrata CDR1 promoter.
Vu BG; Moye-Rowley WS
Genetics; 2022 Sep; 222(2):. PubMed ID: 36063046
[TBL] [Abstract][Full Text] [Related]
5. Loss-of-Function
Ollinger TL; Vu B; Murante D; Parker JE; Simonicova L; Doorley L; Stamnes MA; Kelly SL; Rogers PD; Moye-Rowley WS; Krysan DJ
mSphere; 2021 Dec; 6(6):e0083021. PubMed ID: 34935446
[TBL] [Abstract][Full Text] [Related]
6. Azole-Resistant Alleles of
Vu BG; Moye-Rowley WS
Antimicrob Agents Chemother; 2022 Mar; 66(3):e0209821. PubMed ID: 35007132
[TBL] [Abstract][Full Text] [Related]
7. Identification of genomic binding sites for Candida glabrata Pdr1 transcription factor in wild-type and ρ0 cells.
Paul S; Bair TB; Moye-Rowley WS
Antimicrob Agents Chemother; 2014 Nov; 58(11):6904-12. PubMed ID: 25199772
[TBL] [Abstract][Full Text] [Related]
8. Flucytosine antagonism of azole activity versus Candida glabrata: role of transcription factor Pdr1 and multidrug transporter Cdr1.
Steier Z; Vermitsky JP; Toner G; Gygax SE; Edlind T; Katiyar S
Antimicrob Agents Chemother; 2013 Nov; 57(11):5543-7. PubMed ID: 23979762
[TBL] [Abstract][Full Text] [Related]
9. Positive autoregulation and repression of transactivation are key regulatory features of the Candida glabrata Pdr1 transcription factor.
Khakhina S; Simonicova L; Moye-Rowley WS
Mol Microbiol; 2018 Mar; 107(6):747-764. PubMed ID: 29363861
[TBL] [Abstract][Full Text] [Related]
10. Pdr1 regulates multidrug resistance in Candida glabrata: gene disruption and genome-wide expression studies.
Vermitsky JP; Earhart KD; Smith WL; Homayouni R; Edlind TD; Rogers PD
Mol Microbiol; 2006 Aug; 61(3):704-22. PubMed ID: 16803598
[TBL] [Abstract][Full Text] [Related]
11. Azole resistance in Candida glabrata: coordinate upregulation of multidrug transporters and evidence for a Pdr1-like transcription factor.
Vermitsky JP; Edlind TD
Antimicrob Agents Chemother; 2004 Oct; 48(10):3773-81. PubMed ID: 15388433
[TBL] [Abstract][Full Text] [Related]
12. Negative regulation of Candida glabrata Pdr1 by the deubiquitinase subunit Bre5 occurs in a ubiquitin independent manner.
Paul S; McDonald WH; Moye-Rowley WS
Mol Microbiol; 2018 Oct; 110(2):309-323. PubMed ID: 30137659
[TBL] [Abstract][Full Text] [Related]
13. A Transcriptomics Approach To Unveiling the Mechanisms of
Cavalheiro M; Costa C; Silva-Dias A; Miranda IM; Wang C; Pais P; Pinto SN; Mil-Homens D; Sato-Okamoto M; Takahashi-Nakaguchi A; Silva RM; Mira NP; Fialho AM; Chibana H; Rodrigues AG; Butler G; Teixeira MC
Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30348666
[No Abstract] [Full Text] [Related]
14. Functional information from clinically-derived drug resistant forms of the Candida glabrata Pdr1 transcription factor.
Simonicova L; Moye-Rowley WS
PLoS Genet; 2020 Aug; 16(8):e1009005. PubMed ID: 32841236
[TBL] [Abstract][Full Text] [Related]
15. STB5 is a negative regulator of azole resistance in Candida glabrata.
Noble JA; Tsai HF; Suffis SD; Su Q; Myers TG; Bennett JE
Antimicrob Agents Chemother; 2013 Feb; 57(2):959-67. PubMed ID: 23229483
[TBL] [Abstract][Full Text] [Related]
16. Impact of the Major Candida glabrata Triazole Resistance Determinants on the Activity of the Novel Investigational Tetrazoles VT-1598 and VT-1161.
Nishimoto AT; Whaley SG; Wiederhold NP; Zhang Q; Yates CM; Hoekstra WJ; Schotzinger RJ; Garvey EP; Rogers PD
Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31383660
[TBL] [Abstract][Full Text] [Related]
17. Inhibiting fungal multidrug resistance by disrupting an activator-Mediator interaction.
Nishikawa JL; Boeszoermenyi A; Vale-Silva LA; Torelli R; Posteraro B; Sohn YJ; Ji F; Gelev V; Sanglard D; Sanguinetti M; Sadreyev RI; Mukherjee G; Bhyravabhotla J; Buhrlage SJ; Gray NS; Wagner G; Näär AM; Arthanari H
Nature; 2016 Feb; 530(7591):485-9. PubMed ID: 26886795
[TBL] [Abstract][Full Text] [Related]
18. Contribution of CgPDR1-regulated genes in enhanced virulence of azole-resistant Candida glabrata.
Ferrari S; Sanguinetti M; Torelli R; Posteraro B; Sanglard D
PLoS One; 2011 Mar; 6(3):e17589. PubMed ID: 21408004
[TBL] [Abstract][Full Text] [Related]
19. Characterizing Candida glabrata Pdr1, a Hyperactive Transcription Factor Involved in Azole Resistance.
Simonicova L; Moye-Rowley WS
Methods Mol Biol; 2023; 2658():169-179. PubMed ID: 37024701
[TBL] [Abstract][Full Text] [Related]
20. Sterol uptake and sterol biosynthesis act coordinately to mediate antifungal resistance in Candida glabrata under azole and hypoxic stress.
Li QQ; Tsai HF; Mandal A; Walker BA; Noble JA; Fukuda Y; Bennett JE
Mol Med Rep; 2018 May; 17(5):6585-6597. PubMed ID: 29532896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
